Lipid-coated polymeric nanoparticles for cancer drug delivery (Q38556750)

4 September 2017

title

Lipid-coated polymeric nanoparticles for cancer drug delivery (English)

1 reference

4 September 2017

0 references

1 reference

Sangeetha Krishnamurthy

1 reference

4 September 2017

Rajendran Vaiyapuri

1 reference

4 September 2017

Liangfang Zhang

1 reference

4 September 2017

Juliana M Chan

1 reference

4 September 2017

publication date

11 February 2015

1 reference

4 September 2017

1 reference

4 September 2017

1 reference

4 September 2017

1 reference

4 September 2017

page(s)

923-936

1 reference

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Nanoparticles in medicine: therapeutic applications and developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Polymers for drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Biodegradable long-circulating polymeric nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Biodegradation and biocompatibility of PLA and PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Development of lipid-shell and polymer core nanoparticles with water-soluble salidroside for anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Synthesis and characterization of curcumin loaded polymer/lipid based nanoparticles and evaluation of their antitumor effects on MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Steric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Physicochemical and interfacial investigation of lipid/polymer particle assemblies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

New insights into self-organization of a model lipid mixture and quantification of its adsorption on spherical polymer particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Synthesis and characterization of lipid-polymer hybrid nanoparticles with pH-triggered poly(ethylene glycol) shedding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Nanocomplexes based on amphiphilic hyaluronic acid derivative and polyethylene glycol-lipid for ginsenoside rg3 delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Lipid-polymer nanoparticles encapsulating doxorubicin and 2'-deoxy-5-azacytidine enhance the sensitivity of cancer cells to chemical therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Magnetic field activated lipid-polymer hybrid nanoparticles for stimuli-responsive drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

PLGA/polymeric liposome for targeted drug and gene co-delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Delivery of nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Polymer Nanoneedle‐Mediated Intracellular Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Stromal cells and integrins: conforming to the needs of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Photodynamic therapy: combined modality approaches targeting the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Single-step assembly of DOX/ICG loaded lipid--polymer nanoparticles for highly effective chemo-photothermal combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Indocyanine green: intracellular uptake and phototherapeutic effects in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Self-assembled core-shell vascular-targeted nanocapsules for temporal antivasculature and anticancer activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Spatiotemporal controlled delivery of nanoparticles to injured vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

The role of type IV collagen and basement membranes in cancer progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Hypoxia and defective apoptosis drive genomic instability and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Augmentation of therapeutic efficacy in drug-resistant tumor models using ceramide coadministration in temporal-controlled polymer-blend nanoparticle delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Novel nanostructured lipid-dextran sulfate hybrid carriers overcome tumor multidrug resistance of mitoxantrone hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Breast cancer metastasis: markers and models

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

The pathogenesis of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

The cancer stem cell: premises, promises and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Polymer-lipid hybrid nanoparticles conjugated with anti-EGF receptor antibody for targeted drug delivery to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

New technologies for human cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Overview of nanoparticle use in cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Clearance of pathological antibodies using biomimetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

Proofs of the structure of lipid coated nanoparticles (SMBV) used as drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4BM00427B

21 January 2018

Identifiers

DOI

10.1039/C4BM00427B

1 reference

4 September 2017

1 reference